These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 26381852

  • 1. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C, Avril A, Chahboun S, Tierney R, Bak N, Miethe S, Mazuet C, Popoff MR, Thullier P, Hust M, Pelat T, Sesardic D.
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
    Miethe S, Mazuet C, Liu Y, Tierney R, Rasetti-Escargueil C, Avril A, Frenzel A, Thullier P, Pelat T, Urbain R, Fontayne A, Sesardic D, Hust M, Popoff MR.
    PLoS One; 2016; 11(8):e0161446. PubMed ID: 27560688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin.
    Chahboun S, Hust M, Liu Y, Pelat T, Miethe S, Helmsing S, Jones RG, Sesardic D, Thullier P.
    BMC Biotechnol; 2011 Nov 23; 11():113. PubMed ID: 22111995
    [Abstract] [Full Text] [Related]

  • 8. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T, Amatsu S, Misaki R, Yutani M, Du A, Kohda T, Fujiyama K, Ikuta K, Fujinaga Y.
    Toxins (Basel); 2020 May 07; 12(5):. PubMed ID: 32392791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK.
    Protein Pept Lett; 2017 May 07; 24(6):495-502. PubMed ID: 28260503
    [Abstract] [Full Text] [Related]

  • 12. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 13. Production and characterization of a neutralizing antibody against botulinum neurotoxin A.
    Xiong X, Lv S, Fu C, Li L, Sun Z, Han X, Zhang W.
    J Immunol Methods; 2020 Dec 01; 487():112871. PubMed ID: 33007319
    [Abstract] [Full Text] [Related]

  • 14. Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.
    Amersdorfer P, Wong C, Smith T, Chen S, Deshpande S, Sheridan R, Marks JD.
    Vaccine; 2002 Feb 22; 20(11-12):1640-8. PubMed ID: 11858873
    [Abstract] [Full Text] [Related]

  • 15. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E.
    Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J.
    Front Immunol; 2024 Feb 22; 15():1469919. PubMed ID: 39315101
    [Abstract] [Full Text] [Related]

  • 16. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB, Cai S, Adler M, Singh BK, Parmar VS, Singh BR.
    Appl Environ Microbiol; 2018 Dec 15; 84(24):. PubMed ID: 30389764
    [Abstract] [Full Text] [Related]

  • 17. Neutralization mechanism of human monoclonal antibodies against type B botulinum neurotoxin.
    Matsumura T, Kitamura M, Amatsu S, Yamaguchi A, Kobayashi N, Yutani M, Fujinaga Y.
    Microbiol Immunol; 2024 Oct 15; 68(10):348-358. PubMed ID: 39239735
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R, Zhao H, Al-Saleem FH, Ubaid AS, Puligedda RD, Segan AT, Lindorfer MA, Bermudez R, Elias M, Adekar SP, Simpson LL, Taylor RP, Dessain SK.
    Mol Immunol; 2014 Feb 15; 57(2):247-54. PubMed ID: 24184879
    [Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
    Yang GH, Kim KS, Kim HW, Jeong ST, Huh GH, Kim JC, Jung HH.
    Toxicon; 2004 Jul 15; 44(1):19-25. PubMed ID: 15225558
    [Abstract] [Full Text] [Related]

  • 20. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.